Little Rock, ARKANSAS1 Active Studies

Substance Use Disorder Clinical Trials in Little Rock, ARKANSAS

Find 1 actively recruiting substance use disorder clinical trials in Little Rock, ARKANSAS. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
300
Enrolling

Recruiting Substance Use Disorder Studies in Little Rock

About Substance Use Disorder Clinical Trials in Little Rock

Substance use disorder is a condition where the use of substances leads to health issues, disability, and failure to meet responsibilities. It encompasses alcohol, opioid, stimulant, and other drug addictions. Treatment includes behavioral therapy, medication-assisted treatment, and support programs.

There are currently 1 substance use disorder clinical trials recruiting participants in Little Rock, ARKANSAS. These studies are seeking a combined 300 participants. Research is being sponsored by Eli Lilly and Company. Clinical trial participation is free and participants receive study-related medical care at no cost.

Substance Use Disorder Clinical Trials in Little Rock — FAQ

Are there substance use disorder clinical trials in Little Rock?

Yes, there are 1 substance use disorder clinical trials currently recruiting in Little Rock, ARKANSAS. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Little Rock?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Little Rock research site will contact you about next steps.

Are clinical trials in Little Rock free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Little Rock studies also compensate for your time and travel.

What substance use disorder treatments are being tested?

The 1 active trials in Little Rock are testing new therapies including novel drugs, biologics, and treatment approaches for substance use disorder.

Data updated March 2, 2026 from ClinicalTrials.gov